OEA SOURCING GUIDE

What is oleoylethanolamide (OEA)?

A sourcing guide for teams who need to connect an ingredient name with a usable specification and formulation brief.

Start with the ingredient identity

OEA is the abbreviation for oleoylethanolamide, a fatty acid ethanolamide. The name is sometimes written as oleoyl ethanolamide. Check the chemical identifier on your documents rather than relying on a similar-sounding name: PubChem lists OEA as CAS 111-58-0.

Product identity is the first step in a useful supplier comparison. A trade name, a chemical name and a commercial grade describe different things. Your specification should make clear which material the supplier is offering and how its identity is established.

Why does OEA appear in metabolic wellness research?

Researchers have studied OEA in relation to satiety and lipid signaling. A 2003 paper by Fu and colleagues examined its interaction with PPAR-α and reported findings in preclinical models. That is part of the background to interest in this ingredient.

A research paper should be read for its actual methods and limitations. Preclinical results do not establish an effect in people, and a study of one material does not automatically validate another commercial grade. A product team needs to assess whether the supporting evidence is relevant to the proposed ingredient, formulation and intended use.

What does an OEA buyer need to know?

Ask the supplier to identify the offered grade and provide a current specification. Then establish how the OEA content is measured and which other components are present. If two offers state different content percentages, check that they use the same assay and reporting basis before treating the figures as directly comparable.

Separate specification limits from actual lot results. A specification describes acceptance criteria; a certificate of analysis reports information for a particular lot. Your quality team should decide which tests and limits are relevant to its intended product and market.

Build a useful enquiry

A good enquiry explains the destination market, proposed dosage form, estimated quantity and stage of development. It also states which documents your team needs to review. This is more productive than asking for a generic OEA price without identifying the grade or application.

Sample availability, packaging, storage information and delivery terms can then be discussed against that brief. Verify the available supply information before scheduling a manufacturing trial.

Evaluate the actual formulation

An ingredient name does not establish how a material will behave in a blend or finished dosage form. Assess handling and compatibility using the actual sample and your intended processing conditions. Review market suitability and proposed product claims separately from the purchase specification.

For the portfolio overview and enquiry route, visit the Olikong OEA ingredient page.

Sources & scope

START WITH YOUR REQUIREMENTS

Discuss your ingredient project.

Share your destination market, target format, estimated quantity and the documents your team needs.

Request ingredient information